Connection

ALESSIO SIMONETTI to Antidepressive Agents

This is a "connection" page, showing publications ALESSIO SIMONETTI has written about Antidepressive Agents.
Connection Strength

0.145
  1. Reduction in Cognitive Symptoms Following Intranasal Esketamine Administration in Patients With Chronic Treatment-resistant Depression: A 12-Week Case Series. J Psychiatr Pract. 2023 07 01; 29(4):325-332.
    View in: PubMed
    Score: 0.045
  2. Vortioxetine improves physical and cognitive symptoms in patients with post-COVID-19 major depressive episodes. Eur Neuropsychopharmacol. 2023 05; 70:21-28.
    View in: PubMed
    Score: 0.044
  3. Association between duration of lithium exposure and hippocampus/amygdala volumes in type I bipolar disorder. J Affect Disord. 2018 05; 232:341-348.
    View in: PubMed
    Score: 0.031
  4. Mixed depression: clinical features and predictors of its onset associated with antidepressant use. Psychother Psychosom. 2014; 83(4):213-21.
    View in: PubMed
    Score: 0.024
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.